This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Ivan P. Law, MD
Washington, DC

Jorge E. Maldonado, MD, PhD; Edwin D. Bayrd, MD; B. Lawrence Riggs, MD
Rochester, Minn

Arch Intern Med. 1976;136(1):119-120.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.—

We find the case reported by Dr Law of great interest and agree with his comments. Indeed, our patients may be considered to have an increased risk of developing myeloma (that is, premyeloma). One of them (patient 2 of our report) was seen recently, and the level of the monoclonal spike and the number of plasma cells in the bone marrow had increased from previous observations (and after five years from the initial evaluation).

While our paper was being published, Mundy et al¹ reported on a factor that was present in the supernatant fluid of bone marrow cultures of patients with myeloma that accelerated osteoclastic bone resorption in vitro. It is possible that an abnormal, albeit small, clone of plasma cells can produce a serum monoclonal gammopathy and a factor (possibly a "hormone") leading to osteoporosis and that the gammopathy and the osteoporosis may or may not . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?